相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OPTN/SRTR 2019 Annual Data Report: Liver
A. Kwong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study
Nobuhisa Akamatsu et al.
TRANSPLANT INTERNATIONAL (2021)
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation
Isabel M. A. Bruggenwirth et al.
TRANSPLANT INTERNATIONAL (2021)
Current status of liver transplantation in Europe
Philip C. Mueller et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Outcome of patients with acute liver failure awaiting liver transplantation in Japan
Takuya Genda et al.
HEPATOLOGY RESEARCH (2020)
Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
Tetsuo Takehara et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience
Yoshihide Ueda et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society
Koji Umeshita et al.
HEPATOLOGY RESEARCH (2019)
OPTN/SRTR 2016 Annual Data Report: Liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation
Rene Adam et al.
TRANSPLANT INTERNATIONAL (2018)
Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience
Yoshihide Ueda et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review
Dinesh Jothimani et al.
HEPATOLOGY INTERNATIONAL (2016)
Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients
Fredric D. Gordon et al.
LIVER TRANSPLANTATION (2016)
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Reena Ravikumar et al.
JOURNAL OF HEPATOLOGY (2015)
Evaluation for Liver Transplantation in Adults: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Paul Martin et al.
HEPATOLOGY (2014)
Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system
Takuya Genda et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry
H. Egawa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience
Ian A. Rowe et al.
TRANSPLANT INTERNATIONAL (2008)
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation:: A randomized controlled study
Jose A. Carrion et al.
GASTROENTEROLOGY (2007)
Primary sclerosing cholangitis: Summary of a workshop
Nicholas F. LaRusso et al.
HEPATOLOGY (2006)
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores
FY Yao et al.
HEPATOLOGY (2004)
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation:: A randomized study
D Samuel et al.
GASTROENTEROLOGY (2003)
Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center
RFL Garcia et al.
HEPATOLOGY (2001)
HCV-related fibrosis progression following liver transplantation:: increase in recent years
M Berenguer et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
